World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT02223702
Date of registration: 20/08/2014
Prospective Registration: No
Primary sponsor: Kocaeli University
Public title: Alternative Antibiotic Regime in the Treatment of GAgP
Scientific title: Clinical Evaluation of Systemic Moxifloxacin Compared to Amoxicillin Plus Metronidazole Adjunct to Non-surgical Treatment in Generalized Aggressive Periodontitis: A Randomized Clinical Trial
Date of first enrolment: May 2011
Target sample size: 39
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02223702
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Supportive Care. Masking: Double (Investigator, Outcomes Assessor).  
Phase:  Phase 4
Countries of recruitment
Turkey
Contacts
Name:     Esra Guzeldemir-Akcakanat
Address: 
Telephone:
Email:
Affiliation:  Kocaeli University
Key inclusion & exclusion criteria

Inclusion Criteria:

- The periodontal diagnosis of subjects with GAgP was established on the basis of
clinical and radiographic criteria defined by the 1999 International World Workshop
for a Classification of Periodontal Diseases and Conditions.

- Patients were included if they were between 18 and 35 years of age and otherwise
healthy.

Exclusion Criteria:

- if the patients had any known systemic diseases or conditions that can/could influence
the periodontal status (cancer, cardiovascular and respiratory diseases)

- history of hepatitis or HIV infection,

- immunosuppressive chemotherapy

- current pregnancy, planning a pregnancy or lactation

- requirement for antibiotic prophylaxis

- oral diseases other than GAgP, ongoing orthodontic therapy

- a history of antibiotic therapy or periodontal treatment within the preceding six
months.

- Subjects were excluded if they had known allergies to quinolones or penicillin or
metronidazole

- Not willing to participate to the study.

- Not accept to sign written informed consent



Age minimum: 18 Years
Age maximum: 35 Years
Gender: All
Health Condition(s) or Problem(s) studied
Aggressive Periodontitis
Generalized Aggressive Periodontitis
Intervention(s)
Drug: Amoxicillin
Drug: Metronidazole
Drug: Moxifloxacin
Primary Outcome(s)
The Primary Outcome Variable Was Probing Depth. [Time Frame: 6-months]
Secondary Outcome(s)
The Attachment Loss Were Considered as a Secondary Measure. [Time Frame: 6-months]
Secondary ID(s)
KOUKAEK5/9
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available: Yes
Date Posted: 02/11/2018
Date Completed:
URL: https://clinicaltrials.gov/ct2/show/results/NCT02223702
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history